Abstract：Objective To investigate the prognostic value of maximum diameter in axial plane of primary tumor (MDAPPT) on MRI in nasopharyngeal carcinoma (NPC). Methods From 2005 to 2007, 333 patients with newly diagnosed and biopsy-proven NPC without distant metastasis, who underwent MRI scans of the nasopharynx and neck, were included in our study. MDAPPT was measured on MRI. The univariate analysis with the log-rank test and multivariate analysis with the Cox proportional hazards model were used to analyze the relationship between MDAPPT and prognosis. Results The median values of MDAPPT in patients with T1, T2, T3, and T4 NPC were 21.2, 30.0, 38.0, and 52.3 mm, respectively. For all patients with a MDAPPT of ≤30 mm,>30—50 mm, and>50 mm, the 5-year overall survival (OS) rates were 81.3%, 70.1%, and 51.5%, respectively (P=0.000);the 5-year progression-free survival (PFS) rates were 81.3%, 70.0%, and 48.9%, respectively (P=0.000);the 5-year distant metastasis-free survival (DMFS) rates were 85.5%, 86.5%, and 67.2%, respectively (P=0.000);the 5-year local relapse-free survival (LRFS) rates were 97.7%, 91.5%, and 83.3%, respectively (P=0.013). The multivariate analysis showed that MDAPPT was a prognostic factor for PFS and DMFS. For the T3-T4 patients with a MDAPPT of ≤50 mm and>50 mm, the 5-year OS rates were 69.4% and 52.2%(P=0.004), the 5-year PFS rates were 68.0% and 49.6%(P=0.001), and the 5-year DMFS rates were 84.0% and 66.8%(P=0.001). In the patients with a MDAPPT ≤30 mm, the 5-year LRFS rates for those with T1,T2, T3, and T4 NPC were 100%, 95.8%, 96.3%, and 100%, respectively (P=0.643). ConclusionsMDAPPT is a prognostic factor for PFS and DMFS in NPC, and it is an important prognostic factor in patients with T3-T4 NPC. In the NPC patients with a small MDAPPT, local control rate varies little in different T stages.
Liang Shaobo,Zhang Ning,Li Shaoen et al. Prognostic value of maximum diameter in axial plane of primary tumor on MRI in nasopharyngeal carcinoma[J]. Chinese Journal of Radiation Oncology, 2014, 23(1): 43-47.
[1] Lee CC, Huang TT, Lee MS, et al. Clinical application of tumor volume in advanced nasopharyngeal carcinoma to predict outcome[J/OL]. Radiat Oncol,2010,5:20[2013-07-20].http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842277/. [2] Wu Z, Zeng RF, Su Y, et al. Prognostic significance of tumor volume in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy[J]. Head Neck,2013,35:689-694. [3] Chua DT, Sham JS, Kwong DL, et al. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome[J]. Int J Radiat Oncol Biol Phys,1997,39:711-719. [4] Chong VF, Zhou JY, Khoo JB, et al. Nasopharyngeal carcinoma tumor volume measurement[J]. Radiology,2004,231:914-921. [5] Chong VF, Zhou JY, Khoo JB, et al. Correlation between MR imaging-derived nasopharyngeal carcinoma tumor volume and TNM system[J]. Int J Radiat Oncol Biol Phys,2006,64:72-76. [6] 中国鼻咽癌临床分期工作委员会.鼻咽癌′92分期修订工作报告[J].中华放射肿瘤学杂志,2009,18:2-6. [7] Lee A, Poon Y, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976—1985:overall survival and patterns of failure[J]. Int J Radiat Oncol Biol Phys,1992,23:261-270. [8] Xiao WW, Huang SM, Han F, et al. Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy:long-term results of a phase 2 study[J]. Cancer,2011,117:1874-1883. [9] 易俊林,高黎,黄晓东,等.416例鼻咽癌调强放疗远期生存与影响因素分析[J].中华放射肿瘤学杂志,2012,21:196-200. [10] Johnson CR, Thames HD, Huang DT, et al. The tumor volume and clonogen number relationship:tumor control predictions based upon tumor volume estimates derived from computed tomography[J]. Int J Radiat Oncol Biol Phys,1995,33:281-287. [11] Ferrari D, Codecà C, Bertuzzi C, et al. Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population[J/OL]. BMC Cancer,2012,12:208[2013-07-20].http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443044/ [12] 陈传本,潘建基,陈荔莎,等.调强放疗条件下鼻咽癌原发肿瘤体积对预后的影响[J].中华放射肿瘤学杂志,2012,21:205-208. [13] Tang LL, Li L, Mao YP, et al. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imaging:prognostic value and staging categories[J]. Cancer,2008,113:347-354. [14] Liao XB, Mao YP, Liu LZ, et al. How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography[J]? Int J Radiat Oncol Biol Phys, 2008, 72:1368-1377. [15] Willner J, Baier K, Pfreundner L, et al. Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma[J]. Acta Oncol,1999,38:1025-1030. [16] Chu ST, Wu PH, Chou P, et al. Primary tumor volume of nasopharyngeal carcinoma:prognostic significance for recurrence and survival rate[J]. Eur Arch Otorhinolaryngol,2008,265:115-120. [17] Sarisahin M, Cila A, Ozyar E, et al. Prognostic significance of tumor volume in nasopharyngeal carcinoma[J]. Auris Nasus Larynx,2011,38:250-254. [18] Lai SZ, Li WF, Chen L, et al. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients[J]? Int J Radiat Oncol Biol Phys,2011,80:661-668. [19] Peng G, Wang T, Yang KY, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma[J]. Radiother Oncol,2012,104:286-293. [20] Guo R, Sun Y, Yu XL, et al. Is PTV still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma[J]? Radiother Oncol,2012,104:294-299. [21] Chang CC, Chen MK, Liu MT, et al. The effect of primary tumor volumes in advanced T-staged nasopharyngeal tumors[J]. Head Neck,2002,24:940-946.
2014, Vol. 23 
